Total Valuation
Lunai Bioworks has a market cap or net worth of $12.42M. The enterprise value is $16.39M.
Market Cap$12.42M
Enterprise Value$16.39M
Share Statistics
Lunai Bioworks has 4,533,890 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,533,890
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lunai Bioworks’s return on equity (ROE) is 8.34 and return on invested capital (ROIC) is 165.94%.
Return on Equity (ROE)8.34
Return on Assets (ROA)-21.63
Return on Invested Capital (ROIC)165.94%
Return on Capital Employed (ROCE)0.89
Revenue Per Employee0.00
Profits Per Employee-6.14M
Employee Count29
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Lunai Bioworks is ―. Lunai Bioworks’s PEG ratio is -0.01.
PE Ratio―
PS Ratio0.00
PB Ratio-1.76
Price to Fair Value-1.76
Price to FCF-4.78
Price to Operating Cash Flow-1.62
PEG Ratio-0.01
Income Statement
In the last 12 months, Lunai Bioworks had revenue of 0.00 and earned -178.01M in profits. Earnings per share was -86.24.
Revenue0.00
Gross Profit-129.09K
Operating Income-18.55M
Pretax Income-178.01M
Net Income-178.01M
EBITDA-177.15M
Earnings Per Share (EPS)-86.24
Cash Flow
In the last 12 months, operating cash flow was -5.26M and capital expenditures 0.00, giving a free cash flow of -5.26M billion.
Operating Cash Flow-5.26M
Free Cash Flow-5.26M
Free Cash Flow per Share-1.16
Dividends & Yields
Lunai Bioworks pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.61
52-Week Price Change-88.52%
50-Day Moving Average2.77
200-Day Moving Average5.68
Relative Strength Index (RSI)44.63
Average Volume (3m)7.74M
Important Dates
Lunai Bioworks upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Lunai Bioworks as a current ratio of 0.04, with Debt / Equity ratio of -14.77%
Current Ratio0.04
Quick Ratio0.04
Debt to Market Cap0.25
Net Debt to EBITDA-0.06
Interest Coverage Ratio-25.56
Taxes
In the past 12 months, Lunai Bioworks has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Lunai Bioworks EV to EBITDA ratio is -0.27, with an EV/FCF ratio of -6.06.
EV to Sales0.00
EV to EBITDA-0.27
EV to Free Cash Flow-6.06
EV to Operating Cash Flow-6.06
Balance Sheet
Lunai Bioworks has $3.16M in cash and marketable securities with $1.41M in debt, giving a net cash position of $1.74M billion.
Cash & Marketable Securities$3.16M
Total Debt$1.41M
Net Cash$1.74M
Net Cash Per Share$0.38
Tangible Book Value Per Share-$13.32
Margins
Gross margin is -360.71%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-360.71%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Lunai Bioworks is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-63.58%